Implications for multiple sclerosis in the era of the Affordable Care Act: an evolving treatment paradigm.

Abstract excerpt

The treatment paradigm for multiple sclerosis (MS) continues to evolve as additional pharmacotherapeutic options become available. Furthermore, treatment individualization has become more feasible as new medications with distinct mechanisms of action and improved adverse event profiles have reached the market. As such, clinicians should familiarize themselves with the available treatment options, paying...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Therapy
• Share to Multiple Sclerosis
• Share to Phenotype